Cited by 484Influenza Virus Research StudiesVaccine Coverage and HesitancyRespiratory viral infections research

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens.

Nichol, Kristin L., Wuorenma, J., von Sternberg, T.·1998·Archives of Internal Medicine

Open this paper in CoChat — free account

Abstract

BACKGROUND: Vaccination rates for healthy senior citizens are lower than those for senior citizens with underlying medical conditions such as chronic heart or lung disease. Uncertainty about the benefits of influenza vaccination for healthy senior citizens may contribute to lower rates of utilization in this group. OBJECTIVE: To clarify the benefits of influenza vaccination among low-risk senior citizens while concurrently assessing the benefits for intermediate- and high-risk senior citizens. METHODS: All elderly members of a large health maintenance organization were included in each of 6 consecutive study cohorts. Subjects were grouped according to risk status: high risk (having heart or lung disease), intermediate risk (having diabetes, renal disease, stroke and/or dementia, or rheumatologic disease), and low risk. Outcomes were compared between vaccinated and unvaccinated subjects after controlling for baseline demographic and health characteristics. RESULTS: There were more than 20000 subjects in each of the 6 cohorts who provided 147551 person-periods of observation. The pooled vaccination rate was 60%. There were 101 619 person-periods of observation for low-risk subjects, 15 482 for intermediate-risk, and 30 450 for high-risk subjects. Vaccination over the 6 seasons was associated with an overall reduction of 39% for pneumonia hospitalizations (P<.001), a 32% decrease in hospitalizations for all respiratory conditions (P<.001), and a 27% decrease in hospitalizations for congestive heart failure (P<.001). Immunization was also associated with a 50% reduction in all-cause mortality (P<.001). Within the risk subgroups, vaccine effectiveness was 29%, 32%, and 49% for high-, intermediate-, and low-risk senior citizens for reducing hospitalizations for pneumonia and influenza (for high and low risk, P< or =.002; for intermediate risk, P = .11). Effectiveness was 19%, 39%, and 33% (for each, P< or =.008), respectively, for reducing hospitalizations for all respiratory conditions and 49%, 64%, and 55% for reducing deaths from all causes (for each, P<.001). Vaccination was also associated with direct medical care cost savings of $73 per individual vaccinated for all subjects combined (P = .002). Estimates of cost savings within each risk group suggest that vaccination would be cost saving for each subgroup (range of cost savings of $171 per individual vaccinated for high risk to $7 for low risk), although within the subgroups these findings did not reach statistical significance (for each, P> or =.05). CONCLUSIONS: This study confirms that healthy senior citizens as well as senior citizens with underlying medical conditions are at risk for the serious complications of influenza and benefit from vaccination. All individuals 65 years or older should be immunized with this vaccine.

Integrity signals

Registry

Crossref · 10.1001/archinte.158.16.1769

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Prevention and Control of Influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Fiore, A. E., Shay, D. K., Broder, K. R., Iskander, J. K., Uyeki, T. M., Mootrey, G., Bresee, J. S., & Cox, N. S. (2001) · PsycEXTRA Dataset · doi:10.1037/e548312006-001 · Cited by 5,006
State- and sex-specific prevalence of selected characteristics--Behavioral Risk Factor Surveillance System, 1996 and 1997.
Holtzman, D. J., Powell‐Griner, E., Bolen, J. C., & Rhodes, L. (2000) · PubMed · Cited by 1,110
The Efficacy of Influenza Vaccine in Elderly Persons: A Meta-Analysis and Review of the Literature
Gross, P. A., Hermogenes, A. W., Sacks, H. S., Lau, J., & Levandowski, R. A. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-7-199510010-00008 · Cited by 1,100
The Efficacy and Cost Effectiveness of Vaccination against Influenza among Elderly Persons Living in the Community
Nichol, K. L., Margolis, K. L., Wuorenma, J., & Sternberg, T. V. (1994) · New England Journal of Medicine · doi:10.1056/nejm199409223311206 · Cited by 995
The Efficacy of Influenza Vaccination in Elderly Individuals
Govaert, T. M. E. (1994) · JAMA · doi:10.1001/jama.1994.03520210045030 · Cited by 883
SERIOUS MORBIDITY AND MORTALITY ASSOCIATED WITH INFLUENZA EPIDEMICS
GLEZEN, W. P. (1982) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036250 · Cited by 449
Influenza Vaccination Programs for Elderly Persons: Cost-Effectiveness in a Health Maintenance Organization
Mullooly, J. P., Bennett, M. D., Hornbrook, M. C., Barker, W. H., Williams, W. W., Patriarca, P. A., & Rhodes, P. H. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-12-199412150-00008 · Cited by 330
Current Procedural Terminology
Leong, F. T. L. (2008) · Encyclopedia of Counseling · doi:10.4135/9781412963978.n176 · Cited by 326
Impact of influenza epidemics on mortality in the United States from October 1972 to May 1985.
Lui, K., & Kendal, A. P. (1987) · American Journal of Public Health · doi:10.2105/ajph.77.6.712 · Cited by 319
Immunization Policies and Vaccine Coverage Among Adults
Williams, W. W., HICKSON, M. A., KANE, M. A., Kendal, A. P., SPIKA, J. S., & HINMAN, A. R. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-4-616 · Cited by 300

Show all 41 references

Sorted by citations

Items 301–400 of 480

Estimating influenza-related hospital admissions in older people from GP consultation data
Scuffham, P. (2004) · Vaccine · doi:10.1016/j.vaccine.2003.12.022 · Cited by 15
Optimal control of an influenza model with mixed cross-infection by age group
Ya, C., Zhang, J., & Jin, Z. (2022) · Mathematics and Computers in Simulation · doi:10.1016/j.matcom.2022.11.019 · Cited by 14
Effectiveness of influenza vaccination in prevention of influenza-like illness among inhabitants of old folk homes.
Isahak, I., Mahayiddin, A. A., & Ismail, R. (2007) · PubMed · Cited by 14
The Relationship between Influenza Vaccination and Outpatient Visits for Upper Respiratory Infection by the Elderly in Taiwan
Tsai, Y., Huang, W.-F., Wen, Y., & Chen, P. (2007) · Value in Health · doi:10.1111/j.1524-4733.2006.00158.x · Cited by 14
Predictors of Influenza Immunization Among Home Care Clients in Ontario
Hirdes, J. P., Dalby, D. M., Steel, R. K., Carpenter, G., Bernabei, R., Morris, J. N., & Fries, B. E. (2006) · Canadian Journal of Public Health · doi:10.1007/bf03405616 · Cited by 14
Preventing Pneumonia: The Role for Pneumococcal and Influenza Vaccines
Shorr, A. F. (2005) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2004.10.003 · Cited by 14
Effectiveness of influenza vaccination in elderly outpatients in São Paulo city, Brazil
Gutierrez, E. B., Ho Yeh, L. I., SANTOS, A. C. D. S., & Lopes, M. H. (2001) · Revista do Instituto de Medicina Tropical de São Paulo · doi:10.1590/s0036-46652001000600003 · Cited by 14
A case–control study of elderly patients with acute respiratory illness: Effect of influenza vaccination on admission to hospital in winter 2003–2004
Jordan, R. E., Hawker, J. I., Ayres, J. G., Tunnicliffe, W. S., Adab, P., Olowokure, B., Kai, J., McManus, R. J., Salter, R., & Cheng, K. K. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.09.005 · Cited by 14
The Economic Implications of Influenza Vaccination for Adults with Asthma
Trogdon, J. G., Nurmagambetov, T., & Thompson, H. F. (2010) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2010.07.012 · Cited by 13
Vaccine-preventable influenza disease burden from clinical trials of Vaxigrip – an inactivated split virion influenza vaccine – supports wider vaccine use
Arnoux, S., Weinberger, C., & Gessner, B. D. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.08.063 · Cited by 13
Improving seasonal and pandemic influenza vaccines
Saville, M. K., Marsh, G., & Hoffenbach, A. (2008) · Influenza and Other Respiratory Viruses · doi:10.1111/j.1750-2659.2008.00060.x · Cited by 12
Prevalence of influenza immunisation in Australia and suggestions for future targeting of campaigns
WILSON, D. H., Lester, R., Taylor, A. W., Gill, T. K., Grande, E. D., Litt, J. C. B., Kempe, A. E., Campbell, M. S., Miller, N. C., Rixon, G., et al. (2002) · Sozial- und Präventivmedizin · doi:10.1007/bf01318390 · Cited by 13
Influenza vaccination in the elderly: Is a trial on mortality ethically acceptable?
Verhees, R. A. F., Dondorp, W., Thijs, C. T., Dinant, G., & Knottnerus, J. A. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.04.027 · Cited by 12
Strengthening the Nation’s Influenza Vaccination System
Helms, C. M., Guerra, F. A., Klein, J. O., Schaffner, W., Arvin, A. M., & Peter, G. (2005) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2005.05.011 · Cited by 12
Influenza vaccine effectiveness among elderly persons living in the community during the 2003–2004 season
Hara, M., Sakamoto, T., & Tanaka, K. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.06.035 · Cited by 12
Public health responses to influenza in care homes: a questionnaire-based study of local Health Protection Units
Gupta, R. K., Zhao, H., Cooke, M., Harling, R., Regan, M., Bailey, L., & Nguyen‐Van‐Tam, J. S. (2007) · Journal of Public Health · doi:10.1093/pubmed/fdl082 · Cited by 12
Amantadine and pneumonia in elderly stroke patients
Trivalle, C., & Sebag-Lanoë, R. (1999) · The Lancet · doi:10.1016/s0140-6736(05)75594-x · Cited by 12
Vacunación antigripal en atención primaria: análisis del proceso y propuestas para aumentar las tasas de cobertura
Chávarri, H. S., López, J. L. O., Vílchez, A. L., Carbonell, V. P., Orozco‐Beltrán, D., & Gil-Guillén, V. F. (2005) · Atención Primaria · doi:10.1157/13080298 · Cited by 11
The Vote and Vax Program
Shenson, D., & Adams, M. L. (2008) · Journal of Public Health Management and Practice · doi:10.1097/01.phh.0000333883.52893.c8 · Cited by 11
Inactivated influenza vaccines
Keitel, W. A., & Couch, R. B. (2002) · Perspectives in medical virology · doi:10.1016/s0168-7069(02)07008-8 · Cited by 11
Expenditures associated with preventive healthcare
Marin, M. G. (2004) · Preventive Medicine · doi:10.1016/j.ypmed.2004.03.017 · Cited by 12
Influenza
Olshaker, J. S. (2003) · Emergency Medicine Clinics of North America · doi:10.1016/s0733-8627(03)00018-x · Cited by 11
Influencia de las características de los médicos y del cupo en la vacunación antigripal de ancianos en un área de salud de la Comunidad Valenciana
Chávarri, H. S., Carbonell, V. P., López, J. L. O., Beltrán, D. O., Gil-Guillén, V. F., & Climent, M. A. P. (2004) · Atención Primaria · doi:10.1016/s0212-6567(04)79512-8 · Cited by 11
Economic evaluation of MF59 adjuvanted vaccine against influenza in the high-risk elderly population in France
Piercy, J., Ryan, J. A., & Megas, F. (2004) · Journal of Medical Economics · doi:10.3111/200407001018 · Cited by 11
Influenza vaccination coverage in old people’s home in Carmarthenshire, UK, during the winter of 1998/99
Gupta, A., Morris, G., Thomas, P., & Hasan, M. S. (2000) · Vaccine · doi:10.1016/s0264-410x(00)00048-7 · Cited by 11
Italian recommendations for influenza and pneumococcal vaccination in adult patients with autoimmune rheumatic diseases
Guerrini, G., Franzetti, F., Giacomelli, R., Meroni, L., Riva, A., Scirè, C. A., Scrivo, R., Tavio, M., Agostinone, A., Airó, P., et al. (2020) · Clinical and Experimental Rheumatology · doi:10.55563/clinexprheumatol/hj69ne · Cited by 10
Vacunación antigripal en personas mayores
Chaín, G. M., Lázaro, A. M., Pérez, F. A., & Bravo, C. V. (2011) · Revista Española de Geriatría y Gerontología · doi:10.1016/j.regg.2010.10.003 · Cited by 10
The Frequency of Influenza and Pneumococcal Vaccination in COPD
Özsu, S., Uçar, E., Arslan, Y., Maden, E., & Bilgiç, H. (2011) · Solunum · doi:10.5505/solunum.2011.88155 · Cited by 10
2009 update in prevention, evaluation, and outpatient treatment of influenza
Williams, J. M. (2009) · Current Medical Research and Opinion · doi:10.1185/03007990802708244 · Cited by 10
Comparison of two vaccination programmes in preventing influenza-related hospitalization among the elderly during two consecutive seasons
Honkanen, P. O., Läärä, E., Pyhälä, R., Kivelä, S., & Mäkelä, P. H. (2006) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540500532894 · Cited by 10
Influenza vaccination in acute coronary syndromes patients in Thailand: the cost-effectiveness analysis of the prevention for cardiovascular events and pneumonia.
Sribhutorn, A., Phrommintikul, A., Wongcharoen, W., Chaikledkaew, U., Eakanunkul, S., & Sukonthasarn, A. (2018) · Europe PMC (PubMed Central) · doi:10.11909/j.issn.1671-5411.2018.06.008 · Cited by 9
Economic Evaluations of Influenza Vaccination in the Elderly
Wood, S. C., Nguyen, V. H., & Schmidt, C. (2000) · Disease Management & Health Outcomes · doi:10.2165/00115677-200008050-00003 · Cited by 10
Valutazione benefici-costi della vaccinazione antinfluenzale negli anziani in Liguria
Gasparini, R., Luciani, C., Lai, P. L., Maggioni, P., Sticchi, L., Durando, P., Morelli, P., Comino, I., Calderisi, S., & Crovari, P. (2003) · PharmacoEconomics Italian Research Articles · doi:10.1007/bf03320612 · Cited by 10
Cost–benefit evaluation of routine influenza immunization in people 65–74 years of age
Allsup, S. J., Gosney, M., Haycox, A. R., & Regan, M. (2005) · International Journal of Technology Assessment in Health Care · doi:10.1017/s026646230521019x · Cited by 10
Intranasal Cold-Adapted Influenza Virus Vaccine Combined with Inactivated Influenza Virus Vaccines
Targonski, P. V., & Poland, G. A. (2004) · Drugs & Aging · doi:10.2165/00002512-200421060-00001 · Cited by 10
In a prospective observational study, influenza vaccination prevented hospitalization among older home care patients
Landi, F., Onder, G., Cesari, M., Russo, A., Barillaro, C., & Bernabei, R. (2006) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2006.02.017 · Cited by 10
Assessing the impact of confounding (measured and unmeasured) in a case–control study to examine the increased risk of pandemic A/H1N1 associated with receipt of the 2008–9 seasonal influenza vaccine
Rosella, L. C., Groenwold, R. H. H., & Crowcroft, N. S. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.09.132 · Cited by 9
Binding affinity of the L-742,001 inhibitor to the endonuclease domain of A/H1N1/PA influenza virus variants: Molecular simulation approaches
Nguyen, H. V., Nguyen, H. L., Linh, H. Q., & Nguyen, M. T. (2017) · Chemical Physics · doi:10.1016/j.chemphys.2017.11.005 · Cited by 9
Hospital morbidity among elderly patients, before and after influenza vaccination in the state of Paraná
Ferrer, A. L. M., Marcon, S. S., & Santana, R. G. (2008) · Revista Latino-Americana de Enfermagem · doi:10.1590/s0104-11692008000500006 · Cited by 8
Cost and utilization avoidance with mail prompts: a randomized controlled trial.
Berg, G. D., Silverstein, S. M., Thomas, E., & Korn, A. M. (2008) · PubMed · Cited by 8
A randomized controlled trial to evaluate the effect of influenza vaccination and probiotic supplementation on immune response and incidence of influenza-like illness in an elderly population in Indonesia
Koesnoe, S., Masjkuri, N. M. K., Adisasmita, A. C., Djauzi, S., Kartasasmita, C. B., Sundoro, J., Nadjib, M., Korib, M., Muthia, A. N., Muzellina, V. N., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0250234 · Cited by 8
Review of Vaccination Recommendations in Guidelines for Non-Communicable Diseases with Highest Global Disease Burden among Adults 75 Years Old and Above
Ishak, A. R., Hsieh, Y. C., Srinivasan, H., & See, K. C. (2023) · Vaccines · doi:10.3390/vaccines11061076 · Cited by 9
Impact of Influenza Immunization on Medical Expenditures Among Medicare Elderly, 1999–2003
Gilman, B. H., Bonito, A. J., & Eicheldinger, C. R. (2007) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2006.10.010 · Cited by 8
Cardiac injury in patients with pandemic 2009 influenza A (H1N1) infection
Ni, Z., Guo, Z., Chen, X., Wang, Q., Qiu, Y., Wu, T., Yang, Y., & Zhao, L. (2011) · Acta cardiologica. Supplementum · doi:10.1080/ac.66.4.2126589 · Cited by 8
The offset effect of pharmaceutical innovation: A review study
Zozaya, N., Alcalá, B., & Galindo, J. (2019) · Global & Regional Health Technology Assessment · doi:10.1177/2284240319875108 · Cited by 11
Vaccines for Older Adults
Lam, S., & Jodlowski, T. Z. (2009) · The Consultant Pharmacist · doi:10.4140/tcp.n.2009.380 · Cited by 7
Creating Artificial Barriers to Vaccinations
Stefanacci, R. G. (2005) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2005.07.001 · Cited by 7
Severe left ventricular hypertrophy in Anderson-Fabry disease
Bhatia, G. S., Leahy, J. F., Connolly, D. L., & Davis, R. C. (2004) · Heart · doi:10.1136/hrt.2003.031666 · Cited by 7
The seasonality of human mortality: the role of influenza
Reichert, T. A., & Sharma, A. (2001) · International Congress Series · doi:10.1016/s0531-5131(01)00380-6 · Cited by 7
Association of angiotensin‐I converting enzyme DD genotype with influenza pneumonia in the elderly
Onishi, M., Morimoto, S., Yang, J., Okaishi, K., Katsuya, T., Shimizu, M., Okuro, M., Sakurai, S., Onishi, T., & Ogihara, T. (2002) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1046/j.1444-1586.2002.00015.x · Cited by 7
Chronic Obstructive Pulmonary Disease
(2000) · New England Journal of Medicine · doi:10.1056/nejm200012283432615 · Cited by 7
Universal Influenza Vaccination: The Time to Act Is Now
Mair, M., Grow, R. W., Mair, J. S., & Radonovich, L. J. (2006) · Biosecurity and Bioterrorism Biodefense Strategy Practice and Science · doi:10.1089/bsp.2006.4.20 · Cited by 7
Influenza Vaccination by Race among Disabled Community Dwelling Older Women
Frick, K. D., Scanlon, D. P., Bandeen‐Roche, K., Kasper, J. D., Simonsick, E. M., & Sullivan, E. M. (2004) · Journal of Health Care for the Poor and Underserved · doi:10.1353/hpu.2004.0023 · Cited by 7
Seasonal Patterns of Hospital Use in Winnipeg: Implications for Managing Winter Bed Crises
Menec, V. H., Roos, N. P., & MacWilliam, L. (2002) · Healthcare Management Forum · doi:10.1016/s0840-4704(10)60184-6 · Cited by 7
Cross-reactivity of immunoglobulin A secreted on the nasal mucosa in mice nasally inoculated with inactivated H1N1 influenza A viruses in the presence of d-octaarginine-linked polymers
Sakuma, S., Morimoto, N., Nishida, K., Murakami, T., Egawa, T., Endo, R., Kataoka, M., Yamashita, S., Miyata, K., Mohri, K., et al. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.02.010 · Cited by 6
An observational study on pneumococcal and influenza vaccination status of patients with type 2 diabetes mellitus
Bhat, R. A., Wani, S. A., Kharbanda, R., & Sethi, S. (2018) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20184880 · Cited by 6
An electronic medical record reminder is independently associated with improved opportunistic influenza vaccination rates for older inpatients
Chapman, L., Kelly, M., Piggott, R. S., Carr, B., Courtney, G., McDonagh, R., O'Connell, B. C., Bannan, C., Cunningham, C. J., & Briggs, R. (2023) · The Journal of the Royal College of Physicians of Edinburgh · doi:10.1177/14782715231187763 · Cited by 6
Influenza Vaccination: An Unmet Need in Patients With Diabetes
Schaffner, W., Rehm, S. J., & Elasy, T. A. (2007) · Clinical Diabetes · doi:10.2337/diaclin.25.4.145 · Cited by 6
Transition of Patients with COPD Across Different Care Settings: Challenges and Opportunities for Hospitalists
Chuang, C. (2012) · Hospital Practice · doi:10.3810/hp.2012.02.958 · Cited by 6
Measuring preventive procedures by French GPs: an observational survey
Blanquet, M., Gerbaud, L., Noirfalise, C., Llorca, P., Campagne, C., & Malaval, J. (2011) · British Journal of General Practice · doi:10.3399/bjgp11x548947 · Cited by 6
Influvac, a trivalent inactivated subunit influenza vaccine
Zuccotti, G., & Fabiano, V. (2010) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2011.541436 · Cited by 6
Investigation of Binding Affinity between Potential Antiviral Agents and PB2 Protein of Influenza A: Non-equilibrium Molecular Dynamics Simulation Approach
Pham, T. T., Nguyen, H. L., Phan-Toai, T., & Nguyen, H. V. (2020) · International Journal of Medical Sciences · doi:10.7150/ijms.46231 · Cited by 6
Valutazione benefici-costi della vaccinazione antinfluenzale negli anziani in due stagioni epidemiche a confronto nella provincia di Siena
Montomoli, E., Pozzi, T., Alfonsi, V., Ghezzi, B., Pilia, S., Ravasio, R., Lucioni, C., & Gasparini, R. (2003) · PharmacoEconomics Italian Research Articles · doi:10.1007/bf03320613 · Cited by 6
Gnathostomiasis
Parola, P., Dekumyoy, P., Delmont, J. P., & Brouqui, P. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04246-x · Cited by 6
La vaccination pneumococcique en France chez l’adulte
Dubois, G. (2002) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/s0001-4079(19)34145-7 · Cited by 5
Association between monovalent influenza A (H1N1) pdm09 vaccine and pneumonia among the elderly in the 2009–2010 season in Japan: A case-control study
Kondo, K., Suzuki, K., Washio, M., Ohfuji, S., Fukushima, W., Maeda, A., Hirota, Y., & the Pneumonia in Elderly People Study Group (2015) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1016668 · Cited by 5
Cost effectiveness of oseltamivir treatment of influenza: a critique of published methods and outcomes
Postma, M. J., Beardsworth, P., & Wilschut, J. (2008) · Journal of Medical Economics · doi:10.3111/13696990802505557 · Cited by 5
Tendência da mortalidade por causas relacionadas à influenza em idosos no Brasil e evidências de plausibilidade de impacto da vacinação, 1992-2005
Campagna, A. D. S., Duarte, E. C., Daufenbach, L. Z., & Dourado, I. C. (2014) · Epidemiologia e Serviços de Saúde · doi:10.5123/s1679-49742014000100003 · Cited by 5
Influenza
Harper, S. A., Klimov, A. I., Uyeki, T. M., & Fukuda, K. (2002) · Clinics in Laboratory Medicine · doi:10.1016/s0272-2712(02)00022-7 · Cited by 5
The Business Case for Quality: Combining Medical Literature Research with Health Plan Data to Establish Value for Nonclinical Managers
Fetterolf, D. E., & West, R. (2004) · American Journal of Medical Quality · doi:10.1177/106286060401900202 · Cited by 5
Estimating Influenza-Related Hospital Admissions in Children and Adults
Scuffham, P. (2003) · Disease Management & Health Outcomes · doi:10.2165/00115677-200311040-00006 · Cited by 5
Influenza vaccination: the prevalence of risk factors in persons aged 60 years and more in Catalonia
Domı́nguez, Á., Juncà, S., Tresserres, R., Batalla, J., & Salleras, L. (2003) · Vacunas · doi:10.1016/s1576-9887(03)70339-2 · Cited by 5
Mortality due to respiratory diseases in the elderly after influenza vaccination campaigns in the Federal District, Brazil, 1996-2009
Scoralick, F. M., Piazzolla, L. P., Pires, L. L., Neri, C., & de Paula, W. K. (2013) · Jornal Brasileiro de Pneumologia · doi:10.1590/s1806-37132013000200011 · Cited by 4
New Approaches for Managing Influenza in Primary Care
Ehlers, M., Silagy, C. A., Fleming, D., & Freeman, D. (2001) · Clinical Drug Investigation · doi:10.2165/00044011-200121060-00008 · Cited by 4
A case of severe pneumonia caused by multiple bacterial organisms following type B influenza virus infection
Sato, M., Tomioka, E., Horio, J., Chubachi, S., Matsuzaki, T., & Terashima, T. (2014) · Case Reports in Clinical Medicine · doi:10.4236/crcm.2014.31001 · Cited by 3
Diagnosis, Therapy, and Prevention of Influenza
Schaberg, T. (2003) · Pneumologie · doi:10.1055/s-2003-36637 · Cited by 3
Life Satisfaction and Influenza Vaccination Among Older Adults in Canada
Manneh, B., Andrew, M. K., & Okechukwu, C. E. (2022) · Canadian Journal on Aging / La Revue canadienne du vieillissement · doi:10.1017/s0714980822000204 · Cited by 3
Does influenza vaccination of older adult Medicare beneficiaries lower treatment costs for acute and chronic respiratory disease?
Stuart, B., Davidoff, A. J., Lloyd, J. L. E., Shaffer, T., Shoemaker, J. S., & Kemner, J. E. (2010) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2010.05.003 · Cited by 3
Immunisation of Older People
Woodward, M. (2012) · Journal of Pharmacy Practice and Research · doi:10.1002/j.2055-2335.2012.tb00197.x · Cited by 3
Inﬂuenza Vaccine and the Elderly
Kattan, N., & Wooding, F. G. G. (2009) · The Consultant Pharmacist · doi:10.4140/tcp.n.2009.686 · Cited by 3
Vaccine Use in Immunocompromised Adults
Whitaker, J. A., Valles, K. A., Tosh, P. K., & Poland, G. A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-55435-0.00009-4 · Cited by 3
Vaccination in Patients with Autoimmune Inflammatory Rheumatic Diseases
Watad, ‬., Soriano, A., & Shoenfeld, Y. (2015) · doi:10.1002/9781118663721.ch12 · Cited by 3
Influenza as a bioterror threat: the need for global vaccination
Madjid, M., & Casscells, W. (2004) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.4.3.265 · Cited by 3
Modulation of cytokeratin and cytokine/chemokine expression following influenza virus infection of differentiated human tonsillar epithelial cells
Perry, S., Brice, D. C., Sakr, A., Kandeil, A., DeBeauchamp, J., Ghonim, M. A., Jones, J. C., Miller, L., Vegesana, K., Crawford, J. C., et al. (2025) · Journal of Virology · doi:10.1128/jvi.01460-24 · Cited by 2
Effect of Influenza Vaccination on the Disease Severity and Viral Load Among Adult Outpatients and Inpatients
Domnich, A., Paolozzi, V., Garzillo, G., Orsi, A., & Icardi, G. (2025) · Vaccines · doi:10.3390/vaccines13101046 · Cited by 2
Trivalent inactivated influenza vaccine response and immunogenicity assessment after one week and three months in repeatedly vaccinated adults
Tawfik, A., Kawaguchi, T., Takahashi, M., Setoh, K., Yamaguchi, I., Tabara, Y., Steen, K. V., Sakuntabhai, A., & Matsuda, F. (2023) · Expert Review of Vaccines · doi:10.1080/14760584.2023.2262563 · Cited by 2
Vaccination for Patients with Rheumatic Diseases in the Era of Biologics
Han, S. H. (2018) · Journal of Rheumatic Diseases · doi:10.4078/jrd.2018.25.2.100 · Cited by 2
Consenso de recomendaciones de vacunas en adultos con enfermedades reumaticas inflamatorias cronicas autoinmunes
Cosentino, V. L., Larroudé, M. S., Schneeberger, E. E., de Infectología, G. D. E. D. L. S. A., & Nacinovich, F. (2022) · Revista Argentina de Reumatología · doi:10.47196/rar.v33i1sup.614 · Cited by 2
Economic Analyses of Vaccine Policies
Miller, M. A., & Gessner, B. D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35761-6.00078-x · Cited by 2
Impacto de una estrategia de vacunación antigripal en el servicio de prevención de enfermedades cardiovasculares
Vallejo, R., Marí, M. P. L., & Bravo, M. Á. Q. (2009) · Revista de Calidad Asistencial · doi:10.1016/s1134-282x(09)70070-3 · Cited by 2
Cost-effective approaches to influenza prevention and treatment
Rothberg, M. B. (2005) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/14737167.5.2.141 · Cited by 2
Back to Back: We should give the influenza vaccine to elderly patients in rest homes who are suffering from severe dementia: Yes
Jennings, L. (2011) · Journal of Primary Health Care · doi:10.1071/hc11058 · Cited by 2
Diagnosis and treatment of community acquired pneumonia - the German perspective
Welte, T. (2007) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-7563-8_1 · Cited by 2
Clinical Analysis of Community-Acquired Pneumonia and Pulmonary Tuberculosis in the Elderly and Advances in Treatment.
Kobashi, Y., Okimoto, N., Matsushima, T., & SOEJIMA, R. (2001) · Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics · doi:10.3143/geriatrics.38.312 · Cited by 2
Basic principle of population-based cohort study to evaluate influenza vaccine effectiveness among elderly Japanese
Hara, M., & Hirota, Y. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.07.002 · Cited by 2
Diagnosis, Therapy, and Prevention of Influenza
Schaberg, T. (2003) · Pneumologie · doi:10.1055/s-2003-36637-1 · Cited by 2
The COVID-19 vaccine patent: a right without rationale
Althabhawi, N. M., & Al-Ghetaa, A. A. K. (2022) · Medical Humanities · doi:10.1136/medhum-2022-012386 · Cited by 2
Economic analyses of vaccine policies
Miller, M. A., & Hinman, A. R. (2008) · Elsevier eBooks · doi:10.1016/b978-1-4160-3611-1.50076-3 · Cited by 2
A ustralian and N ew Z ealand S ociety for G eriatric M edicine Position Statement – Immunisation of older people
(2016) · Australian Journal on Ageing · doi:10.1111/ajag.12213 · Cited by 2
Effect of Influenza Vaccination in Patients with Cardiovascular Disease: An Updated Meta-Analysis of Randomized Controlled Trials
Burgos, L. M., Zaidel, E. J., Liprandi, Á. S., & Baranchuk, A. M. (2023) · doi:10.7775/rac.v91.i1.20605 · Cited by 2

Authors: Nichol, K. L., Wuorenma, J., & von Sternberg, T.
Affiliations: University of Minnesota (US)
Regions Hospital (US)
Venue: Archives of Internal Medicine
Publisher: American Medical Association (AMA)
Published: 1998-09-14
Volume: 158
Issue: 16
Pages: 1769
ISSN: 0003-9926 (ISSN-L)
DOI: 10.1001/archinte.158.16.1769
OpenAlex: W2056095352
Cited by: 484
References: 41
Citations by year: 2025: 3 · 2024: 1 · 2023: 9 · 2022: 7 · 2021: 7 · 2020: 4 · 2019: 7 · 2018: 14 · 2017: 15 · 2016: 10 · 2015: 11 · 2014: 6 · 2013: 9 · 2012: 16
FWCI: 15.05
Type: journal article
Language: en
Open access: closed
Locations: Archives of Internal Medicine (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Epidemiology › Influenza Virus Research Studies
Social Sciences › Health › Vaccine Coverage and Hesitancy
Health Sciences › Medicine › Epidemiology › Respiratory viral infections research
Keywords: influenza vaccination, older adults, vaccine effectiveness, pneumonia hospitalization, respiratory hospitalization, congestive heart failure, all-cause mortality, risk stratification, cost reduction, vaccination coverage, health maintenance organizations, diabetes mellitus, kidney disease, dementia, rheumatic diseases
MeSH terms: Aged, Aged, 80 and over, Female, Humans, Influenza, Human, Influenza Vaccines, Male, Risk, Risk Factors, Seasons, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks